Browsing by Author Collins, Michael

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)Citation
2004A Comparison Of The Pharmacokinetics Of Oral And Sublingual Cyproheptadine.Graudins, Andis; Collins, Michael; Gunja, Narendra; MedicineA Comparison Of The Pharmacokinetics Of Oral And Sublingual Cyproheptadine., Clinical Toxicology, vol.42,(1),2004,pp 79-83
2004Cyp3A5 Genotype And Midazolam Clearance In Australian Patients Receiving ChemotherapyBalleine, Rosemary; Clarke, Christine; Gurney, Howard; Liddle, Christopher; Wong, Mark; Collins, Michael; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium InstituteCyp3A5 Genotype And Midazolam Clearance In Australian Patients Receiving Chemotherapy, Clinical Pharmacology & Therapeutics, vol.75,(6),2004,pp 529-538
2009delta(13)C, delta(15)N and delta(2)H isotope ratio mass spectrometry of ephedrine and pseudoephedrine: Application to methylamphetamine profilingSalouros, Helen; Cawley, Adam T; Collins, Michael; Heagney, Aaron C; Kissane, Luke; Robertson, James; Chemistrydelta(13)C, delta(15)N and delta(2)H isotope ratio mass spectrometry of ephedrine and pseudoephedrine: Application to methylamphetamine profiling, Rapid Communications in Mass Spectrometry, vol.23,(13),2009,pp 2003-2010
2015Hyperbaric oxygen therapy for chronic radiation-induced tissue injuries: Australasia's largest studyMcKay, Michael; Collins, Michael; Dass, Joshua; Fon, Peter; Hewitt, Susan; Tahir, Abdul; Webb, Robert; Westhuyzen, Justin; MedicineHyperbaric oxygen therapy for chronic radiation-induced tissue injuries: Australasia's largest study, Asia-Pacific Journal of Clinical Oncology, vol.11, 1, 2015,pp 68-77
2007Imatinib Disposition and ABCB1 (MDR1, P-Glycoprotein) GenotypeBalleine, Rosemary; Clarke, Christine; Gurney, Howard; Hoskins, Janelle; Mann, Graham; McLachlan, Andrew; Rivory, Laurent; Wilcken, Nicholas; Wong, Mark; Collins, Michael; Delforce, S-E; Lynch, Kevin; Schran, H.; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); School of Medical Sciences: Pharmacology; Western Clinical School: Westmead Millennium Institute; Pharmacy; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium InstituteImatinib Disposition and ABCB1 (MDR1, P-Glycoprotein) Genotype, Clinical Pharmacology & Therapeutics, vol.82,(1),2007,pp 33-40
2010Isolation and identification of three by-products found in methylamphetamine synthesized by the Emde routeGeorge, Adrian; Salouros, Helen; Collins, Michael; Davies, Stephen; Chemistry; ChemistryIsolation and identification of three by-products found in methylamphetamine synthesized by the Emde route, Journal of Forensic Sciences, vol.55, 3,pp 605-615
2008N-Cyanomethyl-N-Methyl-1-(3',4'-methylenedioxyphenyl)-2-propylamine: An MDMA Manufacturing By-ProductGeorge, Adrian; Salouros, Helen; Collins, Michael; Tarrant, Gregory; Chemistry; ChemistryN-Cyanomethyl-N-Methyl-1-(3',4'-methylenedioxyphenyl)-2-propylamine: An MDMA Manufacturing By-Product, Journal of Forensic Sciences, vol.53,(5),2008,pp 1083-1091
2006Predictors of Vinorelbine Pharmacokinetics and Pharmacodynamics in Patients With CancerBlair, Elaine; Clarke, Christine; Farlow, David; Gurney, Howard; Hoskins, Janelle; Mann, Graham; McLachlan, Andrew; Rivory, Laurent; Ackland, Stephen P.; Balleine, Rosemary; Collins, Michael; Evans, Scott; Garg, M. B.; WONG, Mark; Pharmacy; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Imaging; Western Clinical School: Medicine (Westmead); School of Medical Sciences: Pharmacology; Western Clinical School: Westmead Millennium Institute; Pharmacy; Central Clinical School: MedicinePredictors of Vinorelbine Pharmacokinetics and Pharmacodynamics in Patients With Cancer, JOURNAL OF CLINICAL ONCOLOGY 2005, vol.24,(16),2006,pp 2448-2455